Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second ‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis

American Journal of Hematology, EarlyView.

Source: American Journal of Hematology - April 28, 2018 Category: Hematology Authors: GiovanniCaocci , OlgaMulas , MarioAnnunziata , LuigianaLuciano , MassimilianoBonifacio , Ester MariaOrlandi , PatriziaPregno , SaraGalimberti , AntonellaRusso Rossi , ElisabettaAbruzzese , AlessandraIurlo , BrunoMartino Source Type: research